TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23627719

Group type: EXPERIMENTAL
Intervention: Winning among larger groups (many competitors)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Winning among smaller groups (few competitors)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: False feedback of placing in the top 10% in a creativity challenge among many competitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: False feedback of placing in the top 10% in a creativity challenge among few competitors
Number of subjects: 0
Study: 21159220

Group type: EXPERIMENTAL
Intervention: Food opportunities during the school day
Number of subjects: 145
Study: 19587123

Group type: EXPERIMENTAL
Intervention: Carbohydrate-restricted diet (CRD) for 6 weeks
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Carbohydrate-restricted diet (CRD) continued for an additional 6 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: AHA diet (55% carbohydrate, 25-30% fat, 15-20% protein) for 6 weeks
Number of subjects: 39
Study: 18021533

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha)
Number of subjects: 542

Group type: COMPARATOR
Intervention: Control (non-antiviral interventions)
Number of subjects: 542
Study: 16330292

Group type: EXPERIMENTAL
Intervention: 5 puffs of oral insulin spray
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 10 puffs of oral insulin spray
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 20 puffs of oral insulin spray
Number of subjects: 6

Group type: COMPARATOR
Intervention: Subcutaneously injected regular insulin (0.1 U/kg SC)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 6
Study: 11907619

Group type: EXPERIMENTAL
Intervention: Dual chamber pacing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single chamber ventricular pacing
Number of subjects: 0
Study: 9558132

Group type: EXPERIMENTAL
Intervention: Exogenous melatonin administered 5 hours before DLMO
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salivary DLMO concentration
Number of subjects: 0
Study: 7892486

Group type: EXPERIMENTAL
Intervention: Bolus-triggered helical CT
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional contrast material‐enhanced helical CT
Number of subjects: 30
Study: 1975893

Group type: EXPERIMENTAL
Intervention: Combined 9 and 3 month courses of cyclophosphamide and prednisolone
Number of subjects: 58

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 58
Study: 707354

Group type: EXPERIMENTAL
Intervention: Simplified diet with sodium restriction
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional sodium-fluid restricted diet
Number of subjects: 20
Study: 31531896

Group type: EXPERIMENTAL
Intervention: Dynamic treatment regimes (DTRs) for chronic periodontitis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initial treatment sharing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statistical analysis plan and sample size calculation method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulation studies
Number of subjects: 0
Study: 31111879

Group type: EXPERIMENTAL
Intervention: IVM
Number of subjects: 919

Group type: COMPARATOR
Intervention: IVF
Number of subjects: 919
Study: 28427459

Group type: EXPERIMENTAL
Intervention: Tai Chi training (12-week duration)
Number of subjects: 170
Study: 26270200

Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 70

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 70

Group type: COMPARATOR
Intervention: Quetiapine
Number of subjects: 70
Study: 24369765

Group type: COMPARATOR
Intervention: Low calorie dietary advice + placebo (1 g olive oil)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Low calorie dietary advice emphasising fish + placebo
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Low calorie dietary advice emphasising fish diet + LCn3PUFA supplements
Number of subjects: 118
Study: 21366361

Group type: EXPERIMENTAL
Intervention: Dalcetrapib 3900 mg single dose
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Dalcetrapib 1800-3900 mg/day for 7 days
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Dalcetrapib (all doses)
Number of subjects: 55
Study: 19673746

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg/d)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 17936509

Group type: EXPERIMENTAL
Intervention: LLT intervention group
Number of subjects: 65

Group type: COMPARATOR
Intervention: FASD control group (FASD-C)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Non-exposed control group (NONEXP-C)
Number of subjects: 65
Study: 15585428

Group type: EXPERIMENTAL
Intervention: Hierarchical message (use male condoms; if not, use female condoms; if not, use spermicide)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Male-condom-only message (use male condoms)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Hierarchical message
Number of subjects: 112
Study: 11743900

Group type: EXPERIMENTAL
Intervention: 200 mg sustained-release theophylline preparation twice daily for 4 weeks
Number of subjects: 19
Study: 9210705

Group type: EXPERIMENTAL
Intervention: In situ detection of HCV in liver tissue using a combination of nonradioactive in situ hybridization and immunohistochemistry.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (HCV negative HCC patients and one patient with epithelioid hemangioendothelioma).
Number of subjects: 10
Study: 7950222

Group type: EXPERIMENTAL
Intervention: Geng‐Nian‐Shu (GNS) treatment
Number of subjects: 370

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Geng‐Nian‐Shu (GNS) treatment in ovariectomized white rats
Number of subjects: 370
Study: 31595459

Group type: EXPERIMENTAL
Intervention: Intravenous propofol sedation
Number of subjects: 55
Study: 29654019

Group type: EXPERIMENTAL
Intervention: Fine of DKK250 (€34) for non-attendance
Number of subjects: 6746

Group type: COMPARATOR
Intervention: No fine policy
Number of subjects: 6746

Group type: EXPERIMENTAL
Intervention: Fine policy
Number of subjects: 6746
Study: 28806908

Group type: EXPERIMENTAL
Intervention: OPT OUT - providing all smokers with tobacco-cessation treatment unless they refuse it
Number of subjects: 1000

Group type: COMPARATOR
Intervention: OPT IN - current practice of screening for readiness and only offering treatment to smokers who say they are ready to quit
Number of subjects: 1000
Study: 25656169

Group type: EXPERIMENTAL
Intervention: saxagliptin
Number of subjects: 16492

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16492
Study: 23021943

Group type: EXPERIMENTAL
Intervention: MTCT prophylaxis
Number of subjects: 35
Study: 21105351

Group type: EXPERIMENTAL
Intervention: Sinuforte (INVAR, Russia)
Number of subjects: 0
Study: 18705917

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 64 mmol/day (16 g/day)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200
Study: 16872900

Group type: EXPERIMENTAL
Intervention: Switch Off‐Get Active intervention
Number of subjects: 312
Study: 12826550

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.1% with 0.5 microg x mL(-1) sufentanil (Group R+S0.5)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.1% with 0.75 microg x mL(-1) sufentanil (Group R+S0.75)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.1% with 1 microg x mL(-1) sufentanil (Group R+S1)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: All treatment regimens
Number of subjects: 32
Study: 10997375

Group type: EXPERIMENTAL
Intervention: Formula + LCP
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Human Milk
Number of subjects: 3

Group type: COMPARATOR
Intervention: Formula
Number of subjects: 3
Study: 8782501

Group type: EXPERIMENTAL
Intervention: Ethanol (50 ml of 40 percent ethanol)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (isocaloric placebo with the aroma of rum)
Number of subjects: 36
Study: 1600777

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 6142034

Group type: EXPERIMENTAL
Intervention: Triazolam 0.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lorazepam 2 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31229326

Group type: EXPERIMENTAL
Intervention: Epigallocatechin gallate (EGCG)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 29655114

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy and antidepressants (sertraline and mianserin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 27314465

Group type: EXPERIMENTAL
Intervention: Expert-based neural network model (suicide risk assessment tool)
Number of subjects: 429
Study: 24924278

Group type: EXPERIMENTAL
Intervention: Target contact lens power for distance
Number of subjects: 34

Group type: COMPARATOR
Intervention: 30 D contact lens
Number of subjects: 34

Group type: COMPARATOR
Intervention: Regression-estimated contact lens power
Number of subjects: 34

Group type: COMPARATOR
Intervention: SRK/T-estimated power
Number of subjects: 34
Study: 22385940

Group type: EXPERIMENTAL
Intervention: Prehospital delay less than 1 day
Number of subjects: 1023

Group type: COMPARATOR
Intervention: Prehospital delay
Number of subjects: 1023
Study: 20410617

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Whole blood aggregometer
Number of subjects: 239
Study: 19076849

Group type: EXPERIMENTAL
Intervention: Right ventricular pacing
Number of subjects: 26

Group type: COMPARATOR
Intervention: Biventricular pacing
Number of subjects: 26
Study: 15983223

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 19
Study: 12732833

Group type: EXPERIMENTAL
Intervention: Citric acid solution G
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Citric acid solution R
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study: 11048353

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (CBT) plus disulfiram
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Twelve-Step facilitation (TSF) plus disulfiram
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Clinical management (CM) plus disulfiram
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (CBT) without disulfiram
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Twelve-Step facilitation (TSF) without disulfiram
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Disulfiram (in combination with any treatment)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Initiation of abstinence during treatment
Number of subjects: 96
Study: 8622066

Group type: EXPERIMENTAL
Intervention: Amsacrine (100 mg/m2/d on days 1 to 5) and Etoposide (200 mg/m2/d on days 1 to 3)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Amsacrine and Etoposide plus Azacitidine (250 mg/m2/d on days 4 to 50)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Control group (Amsacrine and Etoposide without Azacitidine)
Number of subjects: 167
Study: 1473880

Group type: EXPERIMENTAL
Intervention: Buffered acetylsalicylic acid (800 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Unbuffered acetylsalicylic acid (500 mg)
Number of subjects: 24
Study: 6378851

Group type: EXPERIMENTAL
Intervention: RT + S (preoperative irradiation to the mediastinum followed by surgery)
Number of subjects: 33

Group type: COMPARATOR
Intervention: SO (surgery only)
Number of subjects: 33
Study: 31888712

Group type: EXPERIMENTAL
Intervention: e‐IPT (internet-based interpersonal psychotherapy)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Routine prenatal care (control)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: e‐IPT
Number of subjects: 160
Study: 28926676

Group type: EXPERIMENTAL
Intervention: Exercise arm (n=43)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control arm (n=44)
Number of subjects: 87
Study: 27465756

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 1019

Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 1019
Study: 25422827

Group type: EXPERIMENTAL
Intervention: Way Milano implants
Number of subjects: 64

Group type: COMPARATOR
Intervention: Kentron implants
Number of subjects: 64
Study: 22326828

Group type: EXPERIMENTAL
Intervention: Intratarsal triamcinolone acetonide (TA) injection
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dexamethasone ointment
Number of subjects: 20
Study: 20012616

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 1650
Study: 17587715

Group type: EXPERIMENTAL
Intervention: High serum IL-10 level (>= 30 pg/ml)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Low serum IL-10 level (<30 pg/ml)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group (healthy and at-risk subjects)
Number of subjects: 250
Study: 10767816

Group type: EXPERIMENTAL
Intervention: ACTIVE treatment (24 sessions of proprioceptive exercises, relaxation, and behavioral support)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: HOME treatment (neck lecture and two sessions of practical training for home exercises)
Number of subjects: 76

Group type: COMPARATOR
Intervention: CONTROL treatment (lecture regarding care of the neck with a recommendation to exercise)
Number of subjects: 76
Study: 9351730

Group type: EXPERIMENTAL
Intervention: Radionuclide measures of residual flow using (99m)Tc sestamibi
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Angiographic flow index (sum of antegrade and collateral flow grades)
Number of subjects: 77
Study: 8441558

Group type: EXPERIMENTAL
Intervention: Exogenous human surfactant substitution at site 2
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Low oxygen requirement during first three neonatal days
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Low mean airway pressure during second and third day
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Low PaCO2 during first two neonatal days
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: No ligation of ductus arteriosus
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Low fluid intake during the first three days
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Low colloid intake during the first two days of life
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Mean airway pressure to oxygen requirement ratio
Number of subjects: 200
Study: 3530586

Group type: EXPERIMENTAL
Intervention: Quazepam 15 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Triazolam 0.25 mg
Number of subjects: 22
Study: 31497883

Group type: EXPERIMENTAL
Intervention: Systemic Therapy Inventory of Change (STIC) feedback system (ROM condition)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Treatment as usual (TAU condition)
Number of subjects: 328
Study: 29505460

Group type: EXPERIMENTAL
Intervention: Healthy Internet Use Program (8 training sessions over 3 months)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 84
Study: 26661065

Group type: EXPERIMENTAL
Intervention: Healthy behaviors and weight-loss intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 24643406

Group type: EXPERIMENTAL
Intervention: Screened patients for stroke rehabilitation trial
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: Potentially eligible patients
Number of subjects: 571
Study: 23155977

Group type: EXPERIMENTAL
Intervention: Ketamine group (intravenous ketamine 0.15 mg/kg pre-induction)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo group (normal saline)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Ketamine group
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study: 20724131

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 356

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 356
Study: 18069036

Group type: EXPERIMENTAL
Intervention: Monthly oral ibandronate 150mg for 3 months
Number of subjects: 350

Group type: COMPARATOR
Intervention: Weekly oral alendronate 70mg for 12 weeks
Number of subjects: 350
Study: 16411527

Group type: EXPERIMENTAL
Intervention: icodextrin
Number of subjects: 40

Group type: COMPARATOR
Intervention: standard glucose solutions (1.36%)
Number of subjects: 40
Study: 12842163

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (normal elderly controls)
Number of subjects: 0
Study: 10379186

Group type: EXPERIMENTAL
Intervention: ASP ventilation (ASPmax and PEA1/2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pressure support ventilation (PSmax and PS1/2)
Number of subjects: 20
Study: 8806116

Group type: EXPERIMENTAL
Intervention: Presence of osteophytes (skyline view)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Presence of osteophytes (anteroposterior view)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Joint space narrowing (all views)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Presence of osteophytes (all views)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Pain in the last year
Number of subjects: 250
Study: 2059395

Group type: EXPERIMENTAL
Intervention: Perindopril (4 to 8 mg/day)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Spironolactone (37.5 to 75 mg/day)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 30861219

Group type: EXPERIMENTAL
Intervention: High-Intensity Resistance and Impact Training (HiRIT)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 86
Study: 27692493

Group type: EXPERIMENTAL
Intervention: High benefits (higher mortality reduction)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Low benefits (lower mortality reduction)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Low benefit-high barrier condition
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: High benefit-low barrier condition
Number of subjects: 218
Study: 25875779

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: 3 mg T enanthate
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: 6.25 mg T enanthate
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: 12.5 mg T enanthate
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: 25 mg T enanthate
Number of subjects: 71
Study: 23597036

Group type: EXPERIMENTAL
Intervention: Multisystemic Therapy (MST)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Care‐As‐Usual (CAU)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MST
Number of subjects: 100

Group type: COMPARATOR
Intervention: CAU
Number of subjects: 100
Study: 21306209

Group type: EXPERIMENTAL
Intervention: Ramelteon 8 mg
Number of subjects: 1130

Group type: EXPERIMENTAL
Intervention: Ramelteon up to 16 mg nightly
Number of subjects: 1130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1130
Study: 19820286

Group type: EXPERIMENTAL
Intervention: Gadodiamide (Omniscan; GE Healthcare)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Non-contrasted MRI (Control)
Number of subjects: 162
Study: 18543495

Group type: EXPERIMENTAL
Intervention: Safflor yellow powder injection (150 mg/d) + Benazepril (10 mg/day)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Benazepril (10 mg/day)
Number of subjects: 76
Study: 16046306

Group type: EXPERIMENTAL
Intervention: Oxyntomodulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 0
Study: 12014437

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Non-Hormone Replacement Therapy (non-HRT)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Grip strength measurement
Number of subjects: 331
Study: 10080880

Group type: EXPERIMENTAL
Intervention: EPO+high Fe (200 U/kg/other day of rhEPO + 12 mg/kg/day of iron)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: EPO+standard Fe (200 U/kg/other day of rhEPO + 4 mg/kg/day of iron)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard Fe (4 mg/kg/day of iron only)
Number of subjects: 21
Study: 7739990

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Both genders
Number of subjects: 252
Study: 2202451

Group type: EXPERIMENTAL
Intervention: 2.5 mg prednisolone daily
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 5.0 mg prednisolone daily
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 7174801

Group type: EXPERIMENTAL
Intervention: Group sessions intervention
Number of subjects: 652
Study: 31654779

Group type: EXPERIMENTAL
Intervention: Teriparatide (20μg subcutaneous daily)
Number of subjects: 1360

Group type: EXPERIMENTAL
Intervention: Benzodiazepines/hypnotics
Number of subjects: 1360

Group type: EXPERIMENTAL
Intervention: SSRIs/SNRIs
Number of subjects: 1360

Group type: COMPARATOR
Intervention: Risedronate (35mg oral weekly)
Number of subjects: 1360
Study: 31010058

Group type: EXPERIMENTAL
Intervention: High fat oral nutritional supplement (HFS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Non-HFS (control group)
Number of subjects: 21
Study: 28142098

Group type: EXPERIMENTAL
Intervention: Clinicians selecting symptoms from a predetermined criteria list
Number of subjects: 113

Group type: COMPARATOR
Intervention: Clinicians freely listing features of the disorders based on their own mental representations
Number of subjects: 113
Study: 26453327

Group type: EXPERIMENTAL
Intervention: Aerobic interval training
Number of subjects: 200

Group type: COMPARATOR
Intervention: Aerobic continuous training
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Aerobic interval training or aerobic continuous training
Number of subjects: 200
Study: 23610112

Group type: EXPERIMENTAL
Intervention: Specific adverse events (AEs) including vasomotor symptoms (VMSs)
Number of subjects: 9325

Group type: EXPERIMENTAL
Intervention: Specific adverse events (AEs) including musculoskeletal adverse events (MSAEs)
Number of subjects: 9325

Group type: EXPERIMENTAL
Intervention: Specific adverse events (AEs) including vulvovaginal symptoms (VVSs)
Number of subjects: 9325
Study: 21474490

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 30